Author:
Herrstedt J�rn,Koeller Jim M.,Roila Fausto,Hesketh Paul J.,Warr David,Rittenberg Cynthia,Dicato Mario
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Adams M, Soukop M, Barley V, et al (1995) Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapy: a randomized trial. Anticancer Drugs 6:514?521
2. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) (1998) Prevention of chemotherapy- and radiotherapy-induced emesis: results of the Perugia Consensus Conference. Ann Oncol 9:811?819
3. ASHP Commission on Therapeutics (1999) ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm 56:729?764
4. Beck TM, York M, Chang A, et al (1997) Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy. S3A-376 Study Group. Cancer Invest 15:297?303
5. Du Bois A, McKenna CJ, Andersson H, Lahousen M, Kitchener H, Pinter T, Capstick V, Wilkinson JR (1997) A randomised, double-blind, parallel-group study to compare the efficacy and safety of ondansetron (GR38032F) plus dexamethasone with metoclopramide plus dexamethasone in the prophylaxis of nausea and emesis induced by carboplatin chemotherapy. Oncology 54:7?14
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献